Table 2 Phenotypic and Genotypic antibiotic resistance rates in K. pneumoniae

Ampicillin

119(98.3%)

Cotrimoxazole

78 (64.4%)

Sulfonamide

sul1

55(70.5%)

sul2

32(41%)

Cefixime

77 (63.6%)

ESBL+

bla _TEM

77(100%)

n:58*

AmpC+

bla _CIT

28(48.3%)

Cefotaxime

77 (63.6%)

bla _CTX−M1

76(98.7%)

bla _CMY−2

26(44.8%)

bla _SHV

76(98.7%)

bla _ACC

4(6.9%)

Ceftriaxone

77 (63.6%)

bla _CTX−M15

73(94.8%)

bla _FOX

0%

Ceftazidime

77 (63.6%)

bla _CTX−M2

0%

bla _MOX

0%

bla _CTX−M8

0%

bla _DHA

0%

Gentamicin

74(61.1%)

Amikacin

41(33.8%)

Tetracycline

56(46.3%)

Tetracycline

tetA

25(44.6%)

Doxycycline

56(46.3%)

Minocycline

56(46.3%)

tetB

17(30.3%)

Tigecycline

2(1.6%)

Ciprofloxacin

52(43%)

Fluoroquinolone

gyrA

27(51.9%)

qnrB

25(48%)

Levofloxacin

52(43%)

qnrS

19(36.5%)

qnrA

11(21.1%)

parC

0%

Ampicillin/sulbactam

58(47.9%)

Piperacillin/tazobactam

55(45.4%)

Imipenem

50(41.3%)

Carbapenemase

Ambler class A blactamases

bla _GES

11(21.5%)

bla _KPC

0%

Meropenem

51(42.1%)

Ambler class B metallo- β -lactamases (MBLs)

bla _NDM

36(70.5%)

bla _VIM

9(17.6%)

Doripenem

51(42.1%)

bla _SIM

0%

bla _GIM

0%

bla _IMP

0%

bla _SPM

0%

Ambler class D b-lactamases

bla _Oxa−48

46(90.1%)

Ertapenem

51(42.1%)

Aztreonam

50(41.3%)

Colistin

4(3.3%)

Fosfomycin

5(4.1%)

Integrase

int1

97(80.1%)

int2

53(43.8%)

int3

0%

Quaternary Ammonium Compounds

qac

53(43.8%)

MDR

63(52%)

XDR

14(11.6%)